| Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital WL Boyko Jr, PJ Yurkowski, MF Ivey, JA Armitstead, BL Roberts American journal of health-system pharmacy 54 (14), 1591-1595, 1997 | 155 | 1997 |
| ASHP guidelines: minimum standard for pharmacies in hospitals TS Brenner, HN Godwin, WA Gouveia, BD Hodgkins, SS Kent, PC Kienle, ... Am J Health Syst Pharm 70 (18), 1619-1630, 2013 | 122 | 2013 |
| Results of an antimicrobial control program at a university hospital C Martin, I Ofotokun, R Rapp, K Empey, J Armitstead, C Pomeroy, ... American Journal of Health-System Pharmacy 62 (7), 732-738, 2005 | 82 | 2005 |
| Medication-error reporting and pharmacy resident experience during implementation of computerized prescriber order entry KA Weant, AM Cook, JA Armitstead American journal of health-system pharmacy 64 (5), 526-530, 2007 | 79 | 2007 |
| Cost effectiveness of a clinical pharmacist on a neurosurgical team KA Weant, JA Armitstead, AM Ladha, D Sasaki-Adams, EJ Hadar, ... Neurosurgery 65 (5), 946-951, 2009 | 72 | 2009 |
| Use of an audience response system to introduce an anticoagulation guide to physicians, pharmacists, and pharmacy students. PJ Trapskin, KM Smith, JA Armitstead, GA Davis American Journal of Pharmaceutical Education 69 (2), 2005 | 37 | 2005 |
| Effect of emergency medicine pharmacists on medication-error reporting in an emergency department KA Weant, RL Humphries, K Hite, JA Armitstead American Journal of Health-System Pharmacy 67 (21), 1851-1855, 2010 | 36 | 2010 |
| Guidelines for the safe handling of hazardous drugs: consensus recommendations BW Chaffee, JA Armitstead, BE Benjamin, MC Cotugno, RA Forrey, ... American Journal of Health-System Pharmacy 67 (18), 1545-1546, 2010 | 30 | 2010 |
| Evolution and operation of a pharmacy residency on-call program KM Smith, KA Hecht, JA Armitstead, GA Davis American journal of health-system pharmacy 60 (21), 2236-2241, 2003 | 28 | 2003 |
| The high-value pharmacy enterprise framework: advancing pharmacy practice in health systems through a consensus-based, strategic approach S Rough, R Shane, JA Armitstead, SM Belford, PW Brummond, D Chen, ... American Journal of Health-System Pharmacy 78 (6), 498-510, 2021 | 23 | 2021 |
| ASHP Foundation pharmacy forecast 2021: strategic planning advice for pharmacy departments in hospitals and health systems JT DiPiro, ER Fox, AS Kesselheim, M Chisholm-Burns, CK Finch, ... American Journal of Health-System Pharmacy 78 (6), 472-497, 2021 | 23 | 2021 |
| Moving antimicrobial stewardship from restriction to facilitation CA Martin, JA Armitstead, RP Mynatt, AD Hoven American Journal of Health-System Pharmacy 68 (2), 109-110, 2011 | 18 | 2011 |
| A Retrospective Evaluation of Vitamin K1 Therapy to Reverse the Anticoagulant Effect of Warfarin J Fan, JA Armitstead, AG Adams, GA Davis Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (10 …, 2003 | 18 | 2003 |
| A medication use evaluation of alendronate: compliance with administration guidelines T Mersfelder, JA Armitstead, MF Ivey, M Cedars Pharmacy practice management quarterly 18 (4), 50-58, 1999 | 18 | 1999 |
| Evidence-based, multidisciplinary approach to the development of a crotalidae polyvalent antivenin (CroFab) protocol at a university hospital KA Weant, PN Johnson, RC Bowers, JA Armitstead Annals of Pharmacotherapy 44 (3), 447-455, 2010 | 15 | 2010 |
| Expanding staff pharmacists' responsibilities to maintain pharmacy services in a neonatal intensive-care unit NH Lobas, JA Armitstead, MF Ivey American Journal of Hospital Pharmacy 48 (8), 1708-1711, 1991 | 15 | 1991 |
| Evaluation of a clinical scoring scale to direct early appropriate therapy in heparin-induced thrombocytopenia SM Wirth, TE Macaulay, JA Armitstead, DT Steinke, MD Blechner, ... Journal of Oncology Pharmacy Practice 16 (3), 161-166, 2010 | 11 | 2010 |
| Drug costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital RP Rapp, ME Evans, C Martin, I Ofotokum, KL Empey, JA Armitstead Current medical research and opinion 20 (4), 469-476, 2004 | 11 | 2004 |
| Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation GM Baker, JE Martin, R Jang, TJ Schroeder, JA Armitstead, S Myre, ... Transplantation proceedings 30 (8), 4082-4084, 1998 | 11 | 1998 |
| Improving the accuracy of patient identification in the medication-use process PJ Trapskin, L White, JA Armitstead American journal of health-system pharmacy 63 (3), 218-222, 2006 | 10 | 2006 |
Kyle WeantAssistant Professor, University of South Carolina在 mailbox.sc.edu 的电子邮件经过验证
